115 related articles for article (PubMed ID: 26938684)
41. Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung.
Lizotte PP; Hanford LE; Enghild JJ; Nozik-Grayck E; Giles BL; Oury TD
BMC Dev Biol; 2007 Mar; 7():15. PubMed ID: 17343756
[TBL] [Abstract][Full Text] [Related]
42. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
[TBL] [Abstract][Full Text] [Related]
43. Serum soluble receptor for advanced glycation end products correlates inversely with measures of adiposity in young adults.
Davis KE; Prasad C; Vijayagopal P; Juma S; Imrhan V
Nutr Res; 2014 Jun; 34(6):478-85. PubMed ID: 25026914
[TBL] [Abstract][Full Text] [Related]
44. Intra-coronary administration of soluble receptor for advanced glycation end-products attenuates cardiac remodeling with decreased myocardial transforming growth factor-beta1 expression and fibrosis in minipigs with ischemia-reperfusion injury.
Lu L; Zhang Q; Xu Y; Zhu ZB; Geng L; Wang LJ; Jin C; Chen QJ; Schmidt AM; Shen WF
Chin Med J (Engl); 2010 Mar; 123(5):594-8. PubMed ID: 20367988
[TBL] [Abstract][Full Text] [Related]
45. Cytotoxic role of advanced glycation end-products in PC12 cells treated with β‑amyloid peptide.
Yan FL; Han GL; Wu GJ
Mol Med Rep; 2013 Aug; 8(2):367-72. PubMed ID: 23799541
[TBL] [Abstract][Full Text] [Related]
46. Evidence for a role of advanced glycation end products in atrial fibrillation.
Raposeiras-Roubín S; Rodiño-Janeiro BK; Grigorian-Shamagian L; Seoane-Blanco A; Moure-González M; Varela-Román A; Álvarez E; González-Juanatey JR
Int J Cardiol; 2012 Jun; 157(3):397-402. PubMed ID: 21652096
[TBL] [Abstract][Full Text] [Related]
47. Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model.
Wang K; Zhou Z; Zhang M; Fan L; Forudi F; Zhou X; Qu W; Lincoff AM; Schmidt AM; Topol EJ; Penn MS
J Pharmacol Exp Ther; 2006 Apr; 317(1):37-43. PubMed ID: 16368901
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
49. Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications.
Lindsey JB; Cipollone F; Abdullah SM; McGuire DK
Diab Vasc Dis Res; 2009 Jan; 6(1):7-14. PubMed ID: 19156622
[TBL] [Abstract][Full Text] [Related]
50. Role of advanced glycation end product (AGE)-induced receptor (RAGE) expression in diabetic vascular complications.
Chawla D; Bansal S; Banerjee BD; Madhu SV; Kalra OP; Tripathi AK
Microvasc Res; 2014 Sep; 95():1-6. PubMed ID: 24984291
[TBL] [Abstract][Full Text] [Related]
51. Paeoniflorin protects HUVECs from AGE-BSA-induced injury via an autophagic pathway by acting on the RAGE.
Chen Y; Du X; Zhou Y; Zhang Y; Yang Y; Liu Z; Liu C; Xie Y
Int J Clin Exp Pathol; 2015; 8(1):53-62. PubMed ID: 25755692
[TBL] [Abstract][Full Text] [Related]
52. Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling.
Liu J; Huang K; Cai GY; Chen XM; Yang JR; Lin LR; Yang J; Huo BG; Zhan J; He YN
Cell Signal; 2014 Jan; 26(1):110-21. PubMed ID: 24113348
[TBL] [Abstract][Full Text] [Related]
53. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Diabetes Metab Res Rev; 2008 Feb; 24(2):109-14. PubMed ID: 17694504
[TBL] [Abstract][Full Text] [Related]
54. In vitro-prepared advanced glycation end-products and the modulating potential of their low-molecular weight degradation products in IRPTC-A rat proximal-tubular derived kidney epithelial cell line.
Deuther-Conrad W; Franke S; Henle T; Sommer M; Stein G
Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL187-96. PubMed ID: 11936867
[TBL] [Abstract][Full Text] [Related]
55. Dietary glycotoxins induce RAGE and VEGF up-regulation in the retina of normal rats.
Kandarakis SA; Piperi C; Moschonas DP; Korkolopoulou P; Papalois A; Papavassiliou AG
Exp Eye Res; 2015 Aug; 137():1-10. PubMed ID: 26026876
[TBL] [Abstract][Full Text] [Related]
56. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
Yamagishi S; Matsui T; Nakamura K; Yoshida T; Takeuchi M; Inoue H; Yoshida Y; Imaizumi T
Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
[TBL] [Abstract][Full Text] [Related]
57. Qifu-Yin attenuates AGEs-induced Alzheimer-like pathophysiological changes through the RAGE/NF-κB pathway.
Wang SY; Liu JP; Ji WW; Chen WJ; Fu Q; Feng L; Ma SP
Chin J Nat Med; 2014 Dec; 12(12):920-8. PubMed ID: 25556063
[TBL] [Abstract][Full Text] [Related]
58. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE).
Oldfield MD; Bach LA; Forbes JM; Nikolic-Paterson D; McRobert A; Thallas V; Atkins RC; Osicka T; Jerums G; Cooper ME
J Clin Invest; 2001 Dec; 108(12):1853-63. PubMed ID: 11748269
[TBL] [Abstract][Full Text] [Related]
59. Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes.
Martín-Carro B; Martín-Vírgala J; Fernández-Villabrille S; Fernández-Fernández A; Pérez-Basterrechea M; Navarro-González JF; Donate-Correa J; Mora-Fernández C; Dusso AS; Carrillo-López N; Panizo S; Naves-Díaz M; Fernández-Martín JL; Cannata-Andía JB; Alonso-Montes C
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982322
[TBL] [Abstract][Full Text] [Related]
60. Atorvastatin inhibits the expression of RAGE induced by advanced glycation end products on aortas in healthy Sprague-Dawley rats.
Xu L; Zang P; Feng B; Qian Q
Diabetol Metab Syndr; 2014; 6(1):102. PubMed ID: 25279006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
